We are live on ! Find out more
Temasek Holdings

Temasek Holdings Portfolio holdings

AUM $30.5B
1-Year Est. Return 13.98%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+13.98%
3 Year Est. Return
+73.05%
5 Year Est. Return
+59.18%
10 Year Est. Return
+409.11%
AUM
$19B
AUM Growth
+$790M
Cap. Flow
+$345M
Cap. Flow %
1.81%
Top 10 Hldgs %
70.05%
Holding
71
New
1
Increased
12
Reduced
5
Closed
9

Top Buys

Rank Stock Value
1
LUMN icon
Lumen
LUMN
+$315M
2
HDB icon
HDFC Bank
HDB
+$75M
3
GPN icon
Global Payments
GPN
+$70.9M
4
MA icon
Mastercard
MA
+$35.4M
5
PYPL icon
PayPal
PYPL
+$35.3M

Top Sells

Rank Stock Value
1
VIRT icon
Virtu Financial
VIRT
+$111M
2
MON
Monsanto Co
MON
+$50.1M
3
BABA icon
Alibaba
BABA
+$19.6M
4
AMRS
Amyris Inc.
AMRS
+$17.6M
5
AMZN icon
Amazon
AMZN
+$10.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 39.73%
2 Communication Services 16.33%
3 Healthcare 13.32%
4 Financials 10.64%
5 Energy 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BA icon
26
Boeing
BA
$165B
$176M 0.93%
525,636
GRA
27
DELISTED
W.R. Grace & Co.
GRA
$160M 0.84%
2,187,501
HDB icon
28
HDFC Bank
HDB
$123B
$146M 0.77%
5,564,660
+3,001,180
+117% +$75M
AQUA
29
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$124M 0.65%
6,037,705
AMZN icon
30
Amazon
AMZN
$2.71T
$112M 0.59%
1,317,360
-126,940
-9% -$10.1M
VNET
31
VNET Group
VNET
$2.21B
$105M 0.55%
10,778,004
CBPO
32
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$98.3M 0.52%
990,000
GPN icon
33
Global Payments
GPN
$22.6B
$97.7M 0.51%
876,176
+627,814
+253% +$70.9M
AVGO icon
34
Broadcom
AVGO
$1.82T
$95.1M 0.5%
3,920,500
+160,000
+4% +$3.92M
CHRS icon
35
Coherus Oncology
CHRS
$217M
$91.8M 0.48%
6,556,116
ILMN icon
36
Illumina
ILMN
$28.1B
$77.4M 0.41%
285,024
TOUR
37
Tuniu
TOUR
$56.8M
$69.4M 0.36%
819,444
IBN icon
38
ICICI Bank
IBN
$108B
$69.4M 0.36%
8,639,819
DNLI icon
39
Denali Therapeutics
DNLI
$3.65B
$67.3M 0.35%
4,410,457
REGN icon
40
Regeneron Pharmaceuticals
REGN
$71.3B
$65.8M 0.35%
190,621
QTTB icon
41
Q32 Bio
QTTB
$339M
$65.7M 0.35%
178,905
KREF
42
KKR Real Estate Finance Trust
KREF
$470M
$48.2M 0.25%
2,439,024
VRTX icon
43
Vertex Pharmaceuticals
VRTX
$123B
$41.6M 0.22%
244,582
EMWP
44
DELISTED
Eros Media World PLC
EMWP
$35.8M 0.19%
137,766
AMGN icon
45
Amgen
AMGN
$198B
$34.8M 0.18%
188,527
BIIB icon
46
Biogen
BIIB
$30B
$34.4M 0.18%
118,644
XTN icon
47
State Street SPDR S&P Transportation ETF
XTN
$413M
$24.5M 0.13%
388,458
NTLA icon
48
Intellia Therapeutics
NTLA
$1.56B
$21.6M 0.11%
790,527
CELG
49
DELISTED
Celgene Corp
CELG
$20.3M 0.11%
255,406
INCY icon
50
Incyte
INCY
$23.2B
$16.9M 0.09%
252,160

Similar funds

Temasek Holdings's Q2 2018 Portfolio in Review

As of Q2 2018, Temasek Holdings held 71 positions worth $19B, up 4.3% from $18.2B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Temasek Holdings's Q2 2018 filing shows 1 new, 12 increased, 5 reduced and 9 closed positions. Its largest new stake was ASLAN Pharmaceuticals Limited American Depositary Shares: 35,562 shares worth $12.7M. The largest sale was Virtu Financial, an estimated $111M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 41% a quarter earlier, followed by Communication Services and Healthcare.

  • Temasek Holdings's largest Q2 2018 buy was ASLAN Pharmaceuticals Limited American Depositary Shares: 35,562 shares worth $12.7M.
  • Temasek Holdings added most to Lumen in Q2 2018, an estimated $315M increase.
  • Temasek Holdings's biggest Q2 2018 reduction was Virtu Financial, cutting an estimated $111M.
  • Temasek Holdings fully exited Monsanto Co in Q2 2018, selling an estimated $50.1M.
  • Temasek Holdings's ten largest holdings make up 70% of its $19B portfolio in Q2 2018.
  • Temasek Holdings opened 1 new position and closed 9 in Q2 2018.
  • Temasek Holdings's portfolio value rose 4.3% quarter-over-quarter to $19B.

Based on Temasek Holdings's 13F filing for Q2 2018, filed 14 Aug 2018.